Iron saccharate NEW

Mechanism of Iron Supplementation: 

Iron sucrose provides direct intravenous supplementation of trivalent iron (Fe³⁺), bypassing intestinal absorption to rapidly elevate serum iron levels for hemoglobin synthesis.

Targeted Release: 

Iron forms a stable complex with sucrose, minimizing free iron toxicity, and is slowly released via the reticuloendothelial system, ensuring high bioavailability.

Primarily indicated for the treatment of iron deficiency anemia, particularly in the following scenarios:

Patients with chronic kidney disease (CKD), especially those undergoing hemodialysis or peritoneal dialysis.

Cases of oral iron intolerance or inadequate response, such as severe gastrointestinal adverse effects or malabsorption.

Situations requiring rapid iron repletion, including preoperative anemia correction and postpartum anemia.

Iron malabsorption due to inflammatory bowel disease (e.g., Crohn’s disease).